Scribner Matt 4
4 · Inogen Inc · Filed Apr 17, 2018
Insider Transaction Report
Form 4
Inogen IncINGN
Scribner Matt
Vice President, Operations
Transactions
- Sale
Common Stock
2018-04-16$140.64/sh−500$70,319→ 5,874 total - Sale
Common Stock
2018-04-16$139.57/sh−2,000$279,146→ 6,374 total - Exercise/Conversion
Stock Option (right to buy)
2018-04-16−2,500→ 7,683 totalExercise: $0.81Exp: 2022-03-28→ Common Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2018-04-16$0.81/sh+2,500$2,025→ 8,374 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2016.
- [F2]Represents the weighted average share price of an aggregate total of 2,000 shares sold in the price range of $139.32 to $139.89 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price
- [F3]Represents the weighted average share price of an aggregate total of 500 shares sold in the price range of $140.43 to $141.03 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F4]Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is April 1, 2012.